Mice injected with Rgs2+CD8+ T cells showed a significantly lower tumor burden than those in the control and Rgs2−CD8+ T cell groups (Figure 6H; Figure S7C, Supporting Information), suggesting the crucial role of Rgs2+CD8+ T cells in antitumor immunity. Here, RGS2 is linked to neoplasm.